Aeris Capital

Total investments

38

Average round size

22M

Portfolio companies

20

Rounds per year

2.24

Lead investments

9

Follow on index

0.47

Exits

12

Stages of investment
SeedPrivate EquityEarly Stage VentureLate Stage Venture
Areas of investment
PublishingBiotechnologyMobileHealth CareGeneticsMedical DeviceMedicalTherapeuticsAdvertisingAdvertising Platforms

Summary

The company was established in Europe in Switzerland. The leading representative office of defined VC is situated in the Pfaffikon.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Aeris Capital, startups are often financed by Mohr Davidow Ventures, Kleiner Perkins, Aberdare Ventures. The meaningful sponsors for the fund in investment in the same round are Mohr Davidow Ventures, BioMedPartners, Life Sciences Partners. In the next rounds fund is usually obtained by Venrock, EDBI, Aster.

We also calculated 4 valuable employees in our database.

The average startup value when the investment from Aeris Capital is 50-100 millions dollars. The important activity for fund was in 2014. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. This Aeris Capital works on 2 percentage points more the average amount of lead investments comparing to the other organizations. The higher amount of exits for fund were in 2014. The fund is constantly included in 2-6 deals per year.

Among the most popular portfolio startups of the fund, we may highlight Butterfly Network, Mode Media, GenomeDx Biosciences. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Health Diagnostics.

Show more

Investments analytics

Analytics

Total investments
38
Lead investments
9
Exits
12
Rounds per year
2.24
Follow on index
0.47
Investments by industry
  • Health Care (20)
  • Biotechnology (16)
  • Medical (14)
  • Therapeutics (10)
  • Mobile (10)
  • Show 35 more
Investments by region
  • United States (26)
  • Germany (7)
  • Israel (1)
  • Canada (3)
  • Switzerland (1)
Peak activity year
2012
Number of Unicorns
1
Number of Decacorns
1

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
16
Avg. valuation at time of investment
80M
Group Appearance index
0.82
Avg. company exit year
10
Avg. multiplicator
0.75
Strategy success index
0.40

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Actona Technologies 16 Aug 2002 E-Commerce, Internet, Software, Content, Business Development, Web Hosting Early Stage Venture 7M United States, California
Cyrkl 17 Sep 2020 B2B, SaaS, Trading Platform, Waste Management, Recycling Seed 236K Czechia, Southeast, Czech Republic
Smaato 02 Dec 2009 Publishing, Mobile, Advertising, Advertising Platforms Early Stage Venture 4M United States, California, San Francisco
Sonetik 24 Jan 2014 Health Care, Medical Device Early Stage Venture Switzerland, Zurich, Zurich
Stat Nurses International 26 Apr 2005 Travel Early Stage Venture 1M United States, Colorado

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.